These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20024902)

  • 1. Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study.
    Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
    Inflamm Bowel Dis; 2010 Aug; 16(8):1367-75. PubMed ID: 20024902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
    Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
    Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
    Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
    Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.
    Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F
    PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.
    Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Goren I; Yahav L; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease serology in Asia and the West.
    Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
    World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
    Yao F; Fan Y; Lv B; Ji C; Xu L
    Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?
    Aloush V; Dotan I; Ablin JN; Elkayam O
    Clin Exp Rheumatol; 2019; 37(1):32-36. PubMed ID: 29998822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
    Smids C; Horjus Talabur Horje CS; Groenen MJM; van Koolwijk EHM; Wahab PJ; van Lochem EG
    Scand J Gastroenterol; 2017 Oct; 52(10):1104-1112. PubMed ID: 28661185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of anti-glycan antibodies in patients with cystic fibrosis.
    Hirche TO; Stein J; Hirche H; Hausmann J; Wagner TO; Behrens F; Schröder O
    Eur J Med Res; 2011 Sep; 16(9):385-90. PubMed ID: 22024437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New serologic markers for inflammatory bowel disease diagnosis.
    Dotan I
    Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
    Papp M; Sipeki N; Tornai T; Altorjay I; Norman GL; Shums Z; Roggenbuck D; Fechner K; Stöcker W; Antal-Szalmas P; Veres G; Lakatos PL
    J Crohns Colitis; 2015 Aug; 9(8):659-68. PubMed ID: 25968583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
    Henckaerts L; Pierik M; Joossens M; Ferrante M; Rutgeerts P; Vermeire S
    Gut; 2007 Nov; 56(11):1536-42. PubMed ID: 17595233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.